Cost-Effectiveness of a Multifaceted Quality Improvement Intervention for Acute Ischemic Stroke in China

被引:27
|
作者
Pan, Yuesong [1 ,2 ]
Zhang, Lei [1 ,2 ,3 ]
Li, Zixiao [1 ,2 ]
Meng, Xia [1 ,2 ]
Wang, Yilong [1 ,2 ]
Li, Hao [1 ,2 ]
Liu, Liping [1 ,2 ]
Wang, Yongjun [1 ,2 ]
机构
[1] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, 119,S 4th Ring W Rd, Beijing 100070, Peoples R China
[2] China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China
[3] Changping Dist Hosp, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
gross domestic product; quality-adjusted life-year; quality improvement; quality of care; uncertainty; PLASMINOGEN-ACTIVATOR; MECHANICAL THROMBECTOMY; RECURRENT STROKE; UTILITY ANALYSIS; MORTALITY; ADJUNCT; HEALTH; ATTACK; RISK;
D O I
10.1161/STROKEAHA.119.027980
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-Multifaceted quality improvement interventions of stroke care have been shown to improve hospital personnel adherence to evidence-based performance measures and subsequent stroke outcomes. This study aimed to evaluate the cost-effectiveness of a multifaceted quality improvement intervention for stroke care in China, the world's largest low- and middle-income country. Methods-A short-term decision tree model and a long-term Markov model were used to analyze the cost-effectiveness of a multifaceted quality improvement intervention for patients with acute ischemic stroke. Outcomes, transition probability, and cost data were obtained from a recent clinical trial and the published literature. The benefit of the intervention was assessed by the costs per quality-adjusted life-years gained in the short- and long-term. One-way and probabilistic sensitivity analyses were performed to assess the uncertainty of the findings. Results-Compared with usual care, a multifaceted quality improvement intervention for stroke care was found to be cost-effective in the first year and highly cost-effective from the second year onward. In the long-term, the intervention yielded a lifetime gain of 0.246 quality-adjusted life-years at an additional cost of Chinese Yuan Renminbi 1510 (US $230), resulting in a cost of Chinese Yuan Renminbi 6138 (US $940) per quality-adjusted life-year gained. Probabilistic sensitivity analysis indicated that the intervention was highly cost-effective in 99.9% of the simulation runs at a willingness-to-pay threshold of Chinese Yuan Renminbi 59 700 (1x gross domestic product per capita of China in 2017, US $9200) per quality-adjusted life-year. Conclusions-A multifaceted quality improvement intervention for stroke care was highly cost-effective in China. The results of this study may be used as a reference for delivering such interventions in low- and middle-income countries and in underserved areas of high-income countries.
引用
收藏
页码:1265 / 1271
页数:7
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS OF ACUTE ISCHEMIC STROKE IN CHINA: MARKOV MATRIX ANALYSES
    Wang, M.
    VALUE IN HEALTH, 2010, 13 (07) : A517 - A517
  • [2] COST-EFFECTIVENESS OF ENDOVASCULAR THERAPY FOR ACUTE ISCHEMIC STROKE WITH LARGE INFARCT IN CHINA
    Pan, Y.
    Huo, X.
    Jin, A.
    Nguyen, T. N.
    Ma, G.
    Tong, X.
    Zhang, X.
    Gao, F.
    Ma, N.
    Mo, D.
    Ren, Z.
    Wang, Y.
    Miao, Z.
    INTERNATIONAL JOURNAL OF STROKE, 2023, 18 (03) : 109 - 110
  • [3] Cost-Effectiveness of Thrombolysis within 4.5 Hours of Acute Ischemic Stroke in China
    Pan, Yuesong
    Chen, Qidong
    Zhao, Xingquan
    Liao, Xiaoling
    Wang, Chunjuan
    Du, Wanliang
    Liu, Gaifen
    Liu, Liping
    Wang, Chunxue
    Wang, Yilong
    Wang, Yongjun
    PLOS ONE, 2014, 9 (10):
  • [4] Cost-effectiveness of endovascular therapy for acute ischemic stroke with large infarct in China
    Pan, Yuesong
    Huo, Xiaochuan
    Jin, Aoming
    Nguyen, Thanh N.
    Ma, Gaoting
    Tong, Xu
    Zhang, Xuelei
    Gao, Feng
    Ma, Ning
    Mo, Dapeng
    Ren, Zeguang
    Wang, Yongjun
    Miao, Zhongrong
    JOURNAL OF NEUROINTERVENTIONAL SURGERY, 2024, 16 (05) : 453 - 458
  • [5] COST-EFFECTIVENESS OF THROMBOLYSIS WITHIN 4.5 HOURS OF ACUTE ISCHEMIC STROKE IN CHINA
    Pan, Y.
    Wang, Y. L.
    Liu, G.
    Zhao, K.
    Wang, Y.
    VALUE IN HEALTH, 2014, 17 (07) : A725 - A725
  • [6] Cost-effectiveness of endovascular therapy for acute ischemic stroke
    Chen, Michael
    NEUROLOGY, 2012, 79 (13) : S16 - S21
  • [7] The cost-effectiveness of telestroke in the treatment of acute ischemic stroke
    Nelson, R. E.
    Saltzman, G. M.
    Skalabrin, E. J.
    Demaerschalk, B. M.
    Majersik, J. J.
    NEUROLOGY, 2011, 77 (17) : 1590 - 1598
  • [8] Cost-effectiveness of improvement strategies for reperfusion treatments in acute ischemic stroke: a systematic review
    Chi Phuong Nguyen
    Willemijn J. Maas
    Durk-Jouke van der Zee
    Maarten Uyttenboogaart
    Erik Buskens
    Maarten M. H. Lahr
    BMC Health Services Research, 23
  • [9] Cost-effectiveness of improvement strategies for reperfusion treatments in acute ischemic stroke: a systematic review
    Nguyen, Chi Phuong J.
    Maas, Willemijn
    van der Zee, Durk-Jouke
    Uyttenboogaart, Maarten
    Buskens, Erik
    Lahr, Maarten M. H.
    BMC HEALTH SERVICES RESEARCH, 2023, 23 (01)
  • [10] Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke
    Riggs, JE
    NEUROLOGY, 1999, 52 (04) : 895 - 895